Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today highlighted a new post hoc analysis of aspirin use in REDUCE-IT® reinforcing that ...
A. The guest you heard was Dr. Sotirios “Sam” Tsimikas. He is one of the world’s foremost experts on Lp (a). People who have ...
Q. I would encourage anyone on the fence about getting the Shingrix vaccine to seriously consider it. My elderly father had the older shingles vaccine but not Shingrix. Several years ago, he had ...
OCEAN, said Albert, provides important risk-benefit data that doctors can now use in discussions with their patients. For ...
OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...
Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group.
These 3 studies, to be presented at the American Heart Association (AHA) Scientific Sessions 2025, explored how these interventions can help reduce cardiovascular and cognitive risks in adults with ...
I do not recommend stopping aspirin without discussing with your doctor. I do not recommend stopping aspirin without discussing with your doctor. I do not recommend stopping aspirin without discussing ...
Philip Morris International Inc. badly mismanaged and ultimately walked away from a lifesaving inhalable version of aspirin ...
The Brighterside of News on MSN
Low-dose aspirin lowers heart attack and stroke risk in Type 2 diabetics.
A new study presented at the American Heart Association’s Scientific Sessions 2025 found that people with Type 2 diabetes and ...
People with type 2 diabetes who took low-dose aspirin were less likely to have a heart attack or stroke, University of ...
Aspirin remains one of the most inexpensive drugs in the pharmacy. A familiar brand name tablet costs less than 6 cents a pill. A bottle containing 300 tablets will set you back under $17. Despite the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results